A detailed history of Pendal Group LTD transactions in Haleon PLC stock. As of the latest transaction made, Pendal Group LTD holds 117,000 shares of HLN stock, worth $1.13 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
117,000
Previous 120,500 2.9%
Holding current value
$1.13 Million
Previous $734,000 27.52%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 19, 2023

SELL
$5.96 - $8.06 $20,860 - $28,210
-3,500 Reduced 2.9%
117,000 $0
Q3 2022

Oct 18, 2022

BUY
$5.63 - $7.5 $678,415 - $903,750
120,500 New
120,500 $734,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Pendal Group LTD Portfolio

Follow Pendal Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pendal Group LTD with notifications on news.